Cefepime/Zidebactam - Wockhardt

Drug Profile

Cefepime/Zidebactam - Wockhardt

Alternative Names: WCK-5222; Zidebactam/cefepime intravenous - Wockhardt

Latest Information Update: 20 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wockhardt
  • Developer Quintiles; Wockhardt
  • Class Antibacterials; Azabicyclo compounds; Cephalosporins; Piperidines; Small molecules; Sulfoxides
  • Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Gram-negative infections

Most Recent Events

  • 28 Jun 2018 Chemical structure information added
  • 07 Jun 2018 Antimicrobial data from in vivo studies in Gram negative infections presented at the ASM Microbe 2018 (ASMM – 2018)
  • 07 Jun 2018 Preclinical data from in vitro studies presented at the ASM Microbe 2018 (ASMM-2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top